Medical Equipment

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-10-26 08:00 1699

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

* Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89; one-sided P = 0.0021). * The 2-year OS rate was 54.1% vs 37.2%, an improvement of 16.9%; with a median follow-u...

2026-10-25 19:12 3474

19th EU-China Business Meeting Concludes! Third-Generation Triple-Helix Biomimetic Collagen Medical Devices Make Their Global Debut, Highlights from the Event

CHENGDU, China, Oct. 24, 2026 /PRNewswire/ -- At the 19th EU-China Business Meeting, co-hosted by the China Chamber of International Commerce (CCOIC) and the European Union Chamber of Commerce in China (EUCCC) in Chengdu, LivingPHOENIX Regenerative Technology Development (Chengdu) Co., Ltd. (her...

2026-10-24 09:29 7572

Johnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise Collaboration

Building on more than five decades in Hong Kong, Johnson & Johnson is committed to advancing better health through science, innovation and collaboration for patients and communities in Hong Kong. The partnership will help strengthen clinical research, develop future healthcare talent and su...

2026-10-22 23:52 3655

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent

* GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. * Georgiamune to receive $45 million in upfront and near-term payments, as part of a total deal value of up to $1.1 billion, plus royalties. FLORENCE, It...

2026-10-22 22:30 3649

ZEISS announces availability of CT LUCIA 621P in Japan, expanding its broad ZEISS Cataract Workflow

The ZEISS CT LUCIA 621P monofocal intraocular lens (IOL) is added to the ZEISS Cataract Workflow in the Japanese market, supporting good visual outcomes for patients. JENA, Germany and TOKYO, Oct. 22, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today the commercial availability of th...

2026-10-22 21:00 1523

Tairex Launches Multi-Agent AI System to Transform Clinical Collaboration and Decision Support

BEIJING, Oct. 22, 2026 /PRNewswire/ -- Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University,unveiled on October 21 the Multidisciplinary Human-Agent Collaboration (MHAC) Ecosystem for Agent Hospital, designed to enable speci...

2026-10-22 17:00 1896

[China's Voice] Preclinical Animal Study: Domestic Neurointerventional Robotic System PANVIS STAR® Completes Validation of Five Major Neurointerventional Procedures

SHANGHAI, Oct. 22, 2026 /PRNewswire/ -- Neurointerventional robots have long remained at the stage of "only being able to assist with angiography." Through close medical-engineering collaboration with Professor Jianmin Liu's team at Shanghai Changhai Hospital, Shenzhen Institute of Advanced Biome...

2026-10-22 14:11 1799

Taimei Technology and GreenLight Clinical Expand Strategic Partnership at AusBiotech 2026 to Pioneer AI-Native Trial Execution Across Asia-Pacific

GOLD COAST, Australia, Oct. 22, 2026 /PRNewswire/ -- Taimei Technology, a global provider of AI-powered clinical development platforms, and GreenLight Clinical (GLC), a physician-led contract research organization (CRO), today announced an expanded strategic partnership at AusBiotech 2026. Evolvi...

2026-10-22 08:00 4183

Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids

DUBLIN, Oct. 22, 2026 /PRNewswire/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced today that its THERAKOS™ CELLEX™ Photopheresis System has received certification under the EU MDR for an ...

2026-10-22 02:01 2870

Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer

* The study evaluates patients with liver cancer at high risk of recurrence following surgical resection * Julie Rosenberg, MD, appointed to leadership team as Chief Medical Officer PHILADELPHIA, Oct. 21, 2026 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focus...

2026-10-21 21:10 4323

HelpMeSee Guwahati Training Operation Reaches 51 Ophthalmologists Across Northeast India

Successful collaboration with HMS Vision Private Limited and Sri Sankaradeva Nethralaya expands access to simulation-based cataract surgical training across four Northeast states GUWAHATI, India, Oct. 21, 2026 /PRNewswire/ -- HelpMeSee and HMS Vision Private Limited, in collaboration with Sri Sa...

2026-10-21 18:30 1359

Telix Reports Third Quarter 2026 Financial Performance

MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026). Q3 2026 Highlights[1] * Group reven...

2026-10-21 06:08 4500

Hospital Authority appreciates generous donation from Sino Group and Ng Teng Fong Charitable Foundation

HONG KONG, Oct. 20, 2026 /PRNewswire/ -- The Hospital Authority (HA) today (October 20) extends its heartfelt gratitude to Sino Group and Ng Teng Fong Charitable Foundation for their generous donation of a combined total of $30 million to support the establishment of two operating theatres dedica...

2026-10-20 18:55 2308

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...

2026-10-20 14:10 1089

Health Innovation South West and Helfie AI announce partnership to evaluate digital-first hypertension screening

Findings from real-world settings will add to the evidence base for preventing cardiovascular disease MELBOURNE, Australia, Oct. 19, 2026 /PRNewswire/ -- Helfie AI and UK-based Health Innovation South West have announced a partnership to explore how digital-first approaches to hypertension scree...

2026-10-19 17:00 3422

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

* Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT). * Secures long-term, priority isotope access for Telix's alpha therapy pipeline, including ...

2026-10-19 13:30 2260

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the precl...

2026-10-19 11:00 3734

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has concluded its inaugural health and life sciences mission to China, advancing priority areas of collaboration designed to accelerate the translation ...

2026-10-18 01:54 5978

Four Leading Institutions Complete Initial Clinical Experience with Spectrum Dynamics Medical's All-Energy Digital SPECT/CT

Experience at institutions from across the globe demonstrated theranostics and imaging across the validated 40-400 keV range and up to 500 keV, with additional scientific and clinical feasibility experience obtained at higher energies, including applications involving Tc-99m, I-123, Lu-177, I-131...

2026-10-15 20:00 2310
12345 ... 94